Associate Professor, Pathology, University of Pittsburgh School of Medicine
Pathology
Dr. Zoltan N. Oltvai, MD
|
|
Give Review
Zoltan N. Oltvai practices Pathology. Zoltan Oltvai is a published doctor. He published 21 publications, including: 'Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion.' Doctor Zoltan N. Oltvai, MD is registered with Medicare and accepts Medicare payments.
Publications
- BalestraWeb: Efficient, online evaluation of drug-target interactions.
- Predicting drug-target interactions using probabilistic matrix factorization.
- Identifying ligand binding conformations of the ?2-adrenergic receptor by using its agonists as computational probes.
- Molecular crowding defines a common origin for the Warburg effect in proliferating cells and the lactate threshold in muscle physiology.
- Comparative genome-scale metabolic reconstruction and flux balance analysis of multiple Staphylococcus aureus genomes identify novel antimicrobial drug targets.
- Impact of limited solvent capacity on metabolic rate, enzyme activities, and metabolite concentrations of S. cerevisiae glycolysis.
- A semi-supervised method for predicting transcription factor-gene interactions in Escherichia coli.
- Shaping specificity in signaling networks.
- A pitfall in series of microarrays: the position of probes affects the cross-correlation of gene expression profiles.
- Exploring transcriptional regulatory networks in the worm.
- The activity reaction core and plasticity of metabolic networks.
- Genome-scale identification of conditionally essential genes in E. coli by DNA microarrays.
- Bioinformatics analysis of experimentally determined protein complexes in the yeast Saccharomyces cerevisiae.
- Bcl-2 promotes premature senescence induced by oncogenic Ras.
- Systems biology. Life's complexity pyramid.
- Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells.
- The metabolic demands of cancer cells are coupled to their size and protein synthesis rates.
- Carbon catabolite repression correlates with the maintenance of near invariant molecular crowding in proliferating E. coli cells.
- Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion.
- Significance of p53 dynamics in regulating apoptosis in response to ionizing radiation, and polypharmacological strategies.
Doctors Specialties
- Clinical Pathology
- Pathology
Accepted Insurances
- Aetna HMO
- Bakery & Confectionary Union Plan
- CoreSource
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- United Healthcare
- Wells Fargo Insurance
Education
-
Washington University - Barnes-Jewish Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679548374 |
| Last Name Of The Provider | OLTVAI |
| First Name Of The Provider | ZOLTAN |
| View All |
Similar Doctors
|
|
Dr. Jeffrey L. Fine, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Hartsock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Guizhu Li, MD |
|
|
Dr. Edward F. Lynch Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jan F. Silverman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alan H. Wells, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xiao-Ming Yin, MD |
|
|
Dr. Bevan Tandon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce S. Rabin, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Debra L. Zynger, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Agata Czapla, MD |